ARCHIVES

Cancer Control Planning Completed, Going Through Final Review Process

This article is from The Cancer Letter archive.

Vol. 01 No. 23 | July 12, 1974

Download PDF Visit The Full Archive

Related Articles

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013

Four CIDAC Contracts Will Go To Cancer Research Centers; RFPs To Be Released January or February

December 20, 1974

Et2’s Referral Guidelines

July 23, 1993